– Traditional clinical trial training presentations can usually be improved. Some study teams have CLEARiTIE work directly with the leaders of each clinical trial to produce highly relevant, concise and clean slides. These slides are then matched with a spoken English script and a presenter to record a video. In a professional studio, the presenter of the video reads the script we prepared into the camera, resulting in videos ranging from 10 to 30 minutes, each covering one topic in a clinical trial investigation training program.
– Traditional clinical trial training meetings take place in 3 or 4 different locations across the globe throughout the year, over long hours. Since there are travel and time costs involved with this method of training, the number of investigators who attend these types of meetings runs on average at 1.5 per hospital participating in the clinical trial. The rest of the team at these hospitals is then indirectly trained by the people who attended the physical meeting, which reduces the quality of the training. Additionally, the people that join each hospital’s team after the physical training has taken place are either indirectly trained or are not trained at all (and don’t participate in the study). Finally, CLEARiTIE uses medically certified translators to raise the quality of training for sites where not all investigators are fluent in English. Using the CLEARiTIE approach the number of investigators being directly trained per site is raised from 1.5 to about 4.5, which translates into more participation, better data and most importantly, safer patients.
– Traditional clinical trial training meetings for a single drug cost pharmaceutical companies millions of dollars every year. Besides creating a measurable cost reduction, our training method allows most parties involved in investigator training to remain productive, due to diminished travel requirements. Overall, the CLEARiTIE approach requires a fraction of the current budget pharmaceutical companies allocate to traditional clinical trial investigator training programs.
Environmental impact reduction:
– Traditional clinical trial training meetings involve hundreds of thousands of passenger/km of air travel and thousands of passenger/km of ground travel. By substantially reducing such travel needs, the carbon emissions reduction allowed by using the CLEARiTIE approach is huge. To assess the magnitude of this advantage, our Environmental Compliance Officer calculates the emission reductions and can assist our client in using these numbers to obtain carbon reduction certificates or offset credits.
Overall, the CLEARiTIE approach allows all investigators to be directly trained, in their own language and at their own time. It is a win-win situation for all parties involved: the pharmaceutical company, its contractors, trainers, trainees and the environment.
Please contact us so we can show you how CLEARiTIE can improve the quality and results of your clinical study.